Cargando…
S100A8 and S100A9 in Hematologic Malignancies: From Development to Therapy
S100A8 and S100A9 are multifunctional proteins that can initiate various signaling pathways and modulate cell function both inside and outside immune cells, depending on their receptors, mediators, and molecular environment. They have been reported as dysregulated genes and proteins in a wide range...
Autores principales: | Razmkhah, Farnaz, Kim, Sena, Lim, Sora, Dania, Abdul-Jalil, Choi, Jaebok |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10488294/ https://www.ncbi.nlm.nih.gov/pubmed/37686186 http://dx.doi.org/10.3390/ijms241713382 |
Ejemplares similares
-
Overexpression of S100A9 in donor T cells is associated with reconstitution of gut microbiota and outcome of allogeneic hematopoietic stem cell transplantation
por: Kim, Sena, et al.
Publicado: (2023) -
S100A8 and S100A9 in experimental osteoarthritis
por: Zreiqat, Hala, et al.
Publicado: (2010) -
Inflammation and pancreatic cancer: molecular and functional interactions between S100A8, S100A9, NT-S100A8 and TGFβ1
por: Basso, Daniela, et al.
Publicado: (2014) -
S100A8, S100A9 and S100A8/A9 heterodimer as novel cachexigenic factors for pancreatic cancer-induced cachexia
por: Liao, Wei-Chih, et al.
Publicado: (2023) -
S100A8/A9 and S100A9 reduce acute lung injury
por: Hiroshima, Yuka, et al.
Publicado: (2017)